To improve cancer care and lower costs, the Centers for Medicare and Medicaid Services created the Enhancing Oncology Model in June 2022.
PITTSBURGH, PA—August 25, 2022—Seven emerging Oncology Nursing Society member leaders under age 40, representing diverse oncology nursing backgrounds around the world, joined the ONS Leadership Development Committee’s 2022 Young Leaders pilot program.
On August 24, 2022, the U.S. Food and Drug Administration approved ibrutinib (Imbruvica®) for pediatric patients aged less than 1 year with chronic graft-versus-host disease after failure of one or more lines of systemic therapy. Formulations include capsules, tablets, and oral suspension.
Vision boards are a collage of images and phrases that represent your goals, dreams, and attitudes; they help you manifest your aspirations by physically placing your thoughts into the world. Although few studies have measured their effectiveness, experts suggest that creating a vision board can help you reach your goals.
With broad backgrounds in oncology genetics, immunology, and disparities, President Joe Biden’s three July 2022 appointments to the Cancer Cabinet will help guide the United States on opportunities to reduce cancer’s barriers and burden for underserved populations.
A compound the body produces when fasting or following a ketogenic diet may slow or stop the growth of colorectal cancer (CRC) cells, according to study results published in Nature.
When OpdualagTM (nivolumab and relatlimab-rmbw), a fixed-dose combination therapy that consists of two distinct monoclonal antibodies, received FDA approval on March 18, 2022, for the treatment of unresectable or metastatic melanoma for adult and pediatric patients 12 years of age or older, it became the first approved combination therapy that includes two distinct immunotherapy agents in a single infusion. Relatlimab-rmbw is also the first approved lymphocyte activation gene-3–blocking antibody.
The U.S. Food and Drug Administration must pull all unauthorized synthetic nicotine products from the market, Robin Koval, CEO and president of Truth Initiative, said in a July 2022 statement.
Monica Bertagnolli, MD, will serve as the next—and first woman—director of the National Cancer Institute. President Joe Biden announced his intent to make the appointment in August 2022.
Three Oncology Nursing Society (ONS) members were honored among the highly distinguished nurse leaders inducted into the American Academy of Nursing’s (AAN’s) 2022 Class of Fellows. In total, 250 inductees—the largest cohort to date—will be recognized at the Academy’s annual conference, taking place on October 27–29, 2022, in Washington, DC.